| Lacey Marie Saurbaugh, CRNP | |
|
1735 Rockvale Rd, Lancaster, PA 17602-1313 | |
| (717) 413-6400 | |
| Not Available |
| Full Name | Lacey Marie Saurbaugh |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 1735 Rockvale Rd, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023776838 | NPI | - | NPPES |
| SP024302 | Other | PA | PA STATE BOARD OF NURSING |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | SP024302 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster General Medical Group | 0941103683 | 463 |
News Archive
Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory.
The National Comprehensive Cancer Network Oncology Research Program is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
In a turnabout, a biochemical self-destruct trigger found in many other types of cells appears to guard the lives of brain cells during an infection with West Nile virus.
› Verified 8 days ago
| Entity Name | Lancaster General Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392383 PECOS PAC ID: 0941103683 Enrollment ID: O20040309000916 |
News Archive
Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory.
The National Comprehensive Cancer Network Oncology Research Program is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
In a turnabout, a biochemical self-destruct trigger found in many other types of cells appears to guard the lives of brain cells during an infection with West Nile virus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lacey Marie Saurbaugh, CRNP 1135 Hampstead Drive, Strasburg, PA 17602 Ph: () - | Lacey Marie Saurbaugh, CRNP 1735 Rockvale Rd, Lancaster, PA 17602-1313 Ph: (717) 413-6400 |
News Archive
Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory.
The National Comprehensive Cancer Network Oncology Research Program is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
In a turnabout, a biochemical self-destruct trigger found in many other types of cells appears to guard the lives of brain cells during an infection with West Nile virus.
› Verified 8 days ago
Jon David Lepley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Duke St, Lancaster, PA 17602 Phone: 717-544-4950 | |
Dr. Lindsi Anne Dearment, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1871 Santa Barbara Dr Ste 1, Lancaster, PA 17601 Phone: 717-560-1970 Fax: 717-560-2278 | |
Emily Kirchner, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-4940 | |
Dr. John T Cotter Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2207 Oregon Pike Ste 202, Lancaster, PA 17601 Phone: 717-560-6470 Fax: 717-560-6472 | |
Dr. Spencer D Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2113 Manor Ridge Dr, Lancaster, PA 17603 Phone: 717-517-7841 Fax: 717-517-7853 | |
Danielle J Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3045 Marietta Ave, Lancaster, PA 17601 Phone: 717-898-2900 | |
Dr. Christine Janouschek, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 S Prince St, Lancaster, PA 17603 Phone: 717-393-7709 |